Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 55.83 Million CAD | 3.77% |
| 2022 | 1.19 Billion CAD | 3.0% |
| 2021 | 1.16 Billion CAD | 9.22% |
| 2020 | 1.06 Billion CAD | -1.53% |
| 2019 | 1.08 Billion CAD | 1.83% |
| 2018 | 1.06 Billion CAD | 2.87% |
| 2017 | 1.03 Billion CAD | 3.02% |
| 2016 | 1 Billion CAD | 8.57% |
| 2015 | 922.14 Million CAD | 20.44% |
| 2014 | 765.64 Million CAD | -60.71% |
| 2013 | 1.94 Billion CAD | 0.82% |
| 2012 | 1.93 Billion CAD | 1226.17% |
| 2011 | 145.73 Million CAD | 6.68% |
| 2010 | 136.6 Million CAD | -1.62% |
| 2009 | 138.85 Million CAD | -5.92% |
| 2008 | 147.59 Million CAD | 16.42% |
| 2007 | 126.77 Million CAD | 102.81% |
| 2006 | 62.5 Million CAD | -35.91% |
| 2005 | 97.53 Million CAD | 33.42% |
| 2004 | 73.1 Million CAD | -10.71% |
| 2003 | 81.87 Million CAD | -94.79% |
| 2002 | 1.57 Billion CAD | 1.42% |
| 2001 | 1.54 Billion CAD | -8.01% |
| 2000 | 1.68 Billion CAD | -3.75% |
| 1999 | 1.74 Billion CAD | -5.92% |
| 1998 | 1.85 Billion CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 14.19 Million CAD | -2.84% |
| 2024 Q1 | 14.61 Million CAD | -95.58% |
| 2023 Q1 | 301.08 Million CAD | -2.64% |
| 2023 Q4 | 330.19 Million CAD | 6.25% |
| 2023 FY | 1.24 Billion CAD | 3.77% |
| 2023 Q3 | 310.78 Million CAD | 3.62% |
| 2023 Q2 | 299.93 Million CAD | -0.38% |
| 2022 Q1 | 295.24 Million CAD | 14.83% |
| 2022 Q4 | 309.23 Million CAD | 0.82% |
| 2022 Q2 | 287.32 Million CAD | -2.68% |
| 2022 Q3 | 306.72 Million CAD | 6.75% |
| 2022 FY | 1.19 Billion CAD | 3.0% |
| 2021 Q1 | 304.83 Million CAD | 10.21% |
| 2021 FY | 1.16 Billion CAD | 9.22% |
| 2021 Q2 | 299.25 Million CAD | -1.83% |
| 2021 Q4 | 257.11 Million CAD | -14.52% |
| 2021 Q3 | 300.8 Million CAD | 0.52% |
| 2020 Q3 | 242.36 Million CAD | -14.5% |
| 2020 Q4 | 276.58 Million CAD | 14.12% |
| 2020 Q2 | 283.46 Million CAD | 8.29% |
| 2020 Q1 | 261.77 Million CAD | -6.0% |
| 2020 FY | 1.06 Billion CAD | -1.53% |
| 2019 Q2 | 268.78 Million CAD | 1.76% |
| 2019 Q1 | 264.14 Million CAD | -4.45% |
| 2019 Q4 | 278.49 Million CAD | 3.53% |
| 2019 FY | 1.08 Billion CAD | 1.83% |
| 2019 Q3 | 269 Million CAD | 0.08% |
| 2018 Q1 | 259.28 Million CAD | -1.07% |
| 2018 FY | 1.06 Billion CAD | 2.87% |
| 2018 Q2 | 260.39 Million CAD | 0.43% |
| 2018 Q3 | 264.92 Million CAD | 1.74% |
| 2018 Q4 | 276.43 Million CAD | 4.35% |
| 2017 Q4 | 262.1 Million CAD | 1.96% |
| 2017 Q1 | 255.04 Million CAD | -2.35% |
| 2017 Q2 | 257.25 Million CAD | 0.87% |
| 2017 FY | 1.03 Billion CAD | 3.02% |
| 2017 Q3 | 257.05 Million CAD | -0.08% |
| 2016 FY | 1 Billion CAD | 8.57% |
| 2016 Q4 | 261.19 Million CAD | 4.29% |
| 2016 Q2 | 242.61 Million CAD | -5.2% |
| 2016 Q3 | 250.44 Million CAD | 3.22% |
| 2016 Q1 | 255.92 Million CAD | -0.38% |
| 2015 FY | 922.14 Million CAD | 20.44% |
| 2015 Q4 | 256.91 Million CAD | 4.24% |
| 2015 Q2 | 226.78 Million CAD | 18.12% |
| 2015 Q1 | 191.98 Million CAD | 123.96% |
| 2015 Q3 | 246.45 Million CAD | 8.68% |
| 2014 FY | 765.64 Million CAD | -60.71% |
| 2014 Q4 | -801.39 Million CAD | -257.15% |
| 2014 Q3 | 509.97 Million CAD | -6.3% |
| 2014 Q2 | 544.25 Million CAD | 6.13% |
| 2014 Q1 | 512.81 Million CAD | 1.02% |
| 2013 Q3 | 485.6 Million CAD | 1.82% |
| 2013 FY | 1.94 Billion CAD | 0.82% |
| 2013 Q4 | 507.63 Million CAD | 4.54% |
| 2013 Q2 | 476.92 Million CAD | -0.29% |
| 2013 Q1 | 478.3 Million CAD | -73.69% |
| 2012 Q4 | 1.81 Billion CAD | 4656.6% |
| 2012 Q2 | 38.18 Million CAD | 7.36% |
| 2012 FY | 1.93 Billion CAD | 1226.17% |
| 2012 Q1 | 35.56 Million CAD | -3.32% |
| 2012 Q3 | 38.21 Million CAD | 0.09% |
| 2011 Q3 | 34.56 Million CAD | -10.33% |
| 2011 Q2 | 38.54 Million CAD | 0.13% |
| 2011 FY | 145.73 Million CAD | 6.68% |
| 2011 Q4 | 36.78 Million CAD | 6.43% |
| 2011 Q1 | 38.49 Million CAD | 7.56% |
| 2010 Q4 | 35.79 Million CAD | 2.7% |
| 2010 Q1 | 32.67 Million CAD | 102.52% |
| 2010 FY | 136.6 Million CAD | -1.62% |
| 2010 Q2 | 33.29 Million CAD | 1.89% |
| 2010 Q3 | 34.85 Million CAD | 4.69% |
| 2009 FY | 138.85 Million CAD | -5.92% |
| 2009 Q1 | 37.64 Million CAD | -8.62% |
| 2009 Q2 | 503.53 Million CAD | 1237.69% |
| 2009 Q3 | 458.03 Million CAD | -9.04% |
| 2009 Q4 | -1.29 Billion CAD | -383.14% |
| 2008 Q1 | 31.11 Million CAD | -54.78% |
| 2008 FY | 147.59 Million CAD | 16.42% |
| 2008 Q4 | 41.19 Million CAD | 17.97% |
| 2008 Q3 | 34.91 Million CAD | -7.71% |
| 2008 Q2 | 37.83 Million CAD | 21.58% |
| 2007 FY | 126.77 Million CAD | 102.81% |
| 2007 Q3 | -312.47 Million CAD | -1827.42% |
| 2007 Q4 | 68.81 Million CAD | 122.02% |
| 2007 Q2 | 18.08 Million CAD | 5.97% |
| 2007 Q1 | 17.07 Million CAD | 262.63% |
| 2006 Q2 | 24.22 Million CAD | -1.11% |
| 2006 Q4 | -10.49 Million CAD | -143.13% |
| 2006 Q1 | 24.49 Million CAD | 0.48% |
| 2006 Q3 | 24.33 Million CAD | 0.47% |
| 2006 FY | 62.5 Million CAD | -35.91% |
| 2005 Q2 | 26.67 Million CAD | 21.93% |
| 2005 Q1 | 21.87 Million CAD | 22.69% |
| 2005 FY | 97.53 Million CAD | 33.42% |
| 2005 Q3 | 25.58 Million CAD | -4.1% |
| 2005 Q4 | 24.37 Million CAD | -4.71% |
| 2004 Q1 | 18.26 Million CAD | -9.39% |
| 2004 Q4 | 17.83 Million CAD | -1.59% |
| 2004 Q3 | 18.11 Million CAD | -4.08% |
| 2004 FY | 73.1 Million CAD | -10.71% |
| 2004 Q2 | 18.88 Million CAD | 3.4% |
| 2003 Q1 | 21.14 Million CAD | 0.0% |
| 2003 FY | 81.87 Million CAD | -94.79% |
| 2003 Q3 | 20.68 Million CAD | 4.1% |
| 2003 Q4 | 20.16 Million CAD | -2.55% |
| 2003 Q2 | 19.87 Million CAD | -6.02% |
| 2002 FY | 1.57 Billion CAD | 1.42% |
| 2001 FY | 1.54 Billion CAD | -8.01% |
| 2000 FY | 1.68 Billion CAD | -3.75% |
| 1999 FY | 1.74 Billion CAD | -5.92% |
| 1998 FY | 1.85 Billion CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | 12.851% |
| Arem Pacific Corporation | 367.08 Thousand USD | -15110.581% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -6595.607% |
| BioCorRx Inc. | 3.84 Million USD | -1353.669% |
| Bionik Laboratories Corp. | 5.81 Million USD | -860.203% |
| Banyan Corp. | 6.59 Million USD | -746.296% |
| Clearday, Inc. | 5 Million USD | -1016.093% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -1604.438% |
| Quantum Medical Transport, Inc. | 874.76 USD | -6382793.594% |
| Empower Clinics Inc. | 6.92 Million USD | -706.592% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -2187.931% |
| Selectis Health, Inc. | 14.36 Million USD | -288.619% |
| Ethema Health Corporation | 5.27 Million USD | -959.065% |
| HealthLynked Corp. | 9.73 Million USD | -473.75% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | -491.536% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -8213.122% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | 25.907% |
| MedSmart Group Inc. | 65.47 Thousand USD | -85182.033% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -7097.504% |
| Nova Leap Health Corp. | 9.3 Million USD | -499.846% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -9989.648% |
| PAO Group, Inc. | 45.42 Thousand USD | -122830.427% |
| Primemd Inc. | 6.25 Million USD | -792.235% |
| Raffles Medical Group Ltd | 151.69 Million USD | 63.192% |
| Ryman Healthcare Limited | 9.61 Million USD | -480.826% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -1318940.869% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -3943.749% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -8953.483% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -7198.693% |
| Veltex Corporation | 1.77 Million USD | -3041.897% |
| World Financial Holding Group | 28.42 Thousand USD | -196322.289% |
| Xcelerate Inc. | 2.9 Million USD | -1820.852% |